Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

GERCOR (France) | Researchclopedia

Back to institutions

GERCOR (France)

Pariscompany

178

Works

18,945

Citations

57

h-index

Top Research Topics

Colorectal Cancer Treatments and Studies Gastric Cancer Management and Outcomes Pancreatic and Hepatic Oncology Research

Top Researchers

Wolf H. Fridman The University of Texas MD Anderson Cancer Center

1,044 works87,850 citationsh-index: 120

Recent Research

Response to: Correspondence on “Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach” by Protzenko <i>et al</i>

Dorian Protzenko,Cecile Berard,et al.

20260 citations

Cancer Treatment and Pharmacology

Genetic factors in colorectal cancer

Cancer Immunotherapy and Biomarkers

Hepatocellular Carcinoma Treatment and Prognosis

Lung Cancer Treatments and Mutations

Colorectal Cancer Surgical Treatments

Cancer Genomics and Diagnostics

Colorectal and Anal Carcinomas

Cholangiocarcinoma and Gallbladder Cancer Studies

Thierry André Inserm

1,216 works64,227 citationsh-index: 105

Catherine Sautès‐Fridman Inserm

603 works47,098 citationsh-index: 95

Aimery de Gramont Institut Hospitalier Franco Britannique

596 works36,326 citationsh-index: 78

Pascal Hammel Université Paris-Saclay

669 works31,265 citationsh-index: 83

Christophe Louvet Institute Mutualiste Montsouris

498 works29,187 citationsh-index: 69

Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach

Dorian Protzenko,Cecile Berard,et al.

20261 citations

Neoadjuvant pembrolizumab with a watch‑and‑wait strategy for localized MSI/dMMR colon cancer: Study protocol for a randomized GERCOR 109 – PRODIGE 84 phase II trial (PREMICES)

Jérémie H. Lefèvre,Olivier Dubreuil,et al.

20251 citations

Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi)

Marine Valéry,Julien Edeline,et al.

20250 citations

812P Efficacy and safety of two schemes of nivolumab (Nivo) and ipilimumab (Ipi) in MSI/dMMR metastatic colorectal cancer (mCRC): The PRODIGE-74 GERCOR NIPISAFE randomized non-comparative phase II trial

Robert Cohen,Christophe Borg,et al.

20250 citations

879eP Nivolumab and ipilimumab in anti-PD1-resistant MSI/dMMR metastatic colorectal cancer: Interim analysis of the GERCOR NIPIRESCUE phase II trial

Romain Cohen,L-J. Palmieri,et al.

20250 citations